Filing Details

Accession Number:
0000899866-15-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-03 21:13:27
Reporting Period:
2015-02-27
Filing Date:
2015-03-03
Accepted Time:
2015-03-03 21:13:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1414815 Martin Mackay C/O Alexion Pharmaceuticals, Inc
352 Knotter Drive
Cheshire CT 06410
Evp & Global Head Of R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Acquisiton 2015-02-27 5,100 $0.00 37,319 No 4 A Direct
Common Stock, Par Value $.0001 Per Share Disposition 2015-03-02 370 $180.34 36,949 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $.0001 Per Share Option to Purchase Common Stock Acquisiton 2015-02-27 24,400 $0.00 24,400 $180.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,400 2016-02-27 2025-02-27 No 4 A Direct
Footnotes
  1. Award of Restricted Stock Units under the 2004 Incentive Plan. 25% vests on each anniversary of the grant date.
  2. This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
  3. 25% vests on the first anniversary of the grant date and 1/16 every three months thereafter.